YESCARTA® (axicabtagene ciloleucel) for Treatment of 2L R/R Large B-Cell Lymphoma | HCP
Official YESCARTA® (axicabtagene ciloleucel) HCP website for 2L relapsed/refractory (R/R) large B-cell lymphoma (LBCL). See full Prescribing Information, including BOXED WARNING.
Keywords:
axicabtagene ciloleucel, yescarta, yescarta treatment centers, yescarta response rate, kite konnect, non-hodgkin lymphoma treatment, yescarta indications
| Created: | 2017-08-22 |
| Expires: | 2028-08-22 |
| Owner: | DN Admin (Kite Pharma Inc.) |
| Hosting company: | CloudFlare, Inc. |
| Registrar: | CSC CORPORATE DOMAINS, INC. |
| IPs: | 104.18.34.227, 172.64.153.29 |
| DNS: |
dns1.cscdns.net dns2.cscdns.net |
| Email: | See owner's emails |
